Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07253532 · ClinicalTrials.gov registry record · NA

Vibrotactile Balance Belt Effect on Improving Gait

A NA study, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target

NCT07253532: Recruiting NA study, sponsored by Johns Hopkins University.

NCT07253532 is a NA study that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07253532, a NA study, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

This study will examine the effect of using a vibrotactile feedback implemented into a belt, at improving gait in those with gait disorders.

Primary Outcome

The Dizziness Handicap Inventory (DHI) is a validated patient-reported outcome measure designed to assess the perceived impact of dizziness on daily function. It includes 25 items categorized into physical, emotional, and functional domains, with responses scored on a scale from 0 (no impact) to 100 (maximum impact). Higher scores indicate greater disability.

Interventions

  • DEVICE BalanceBelt

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2026-03-20
Est. Completion 2030-12-01
Phase NA
Johns Hopkins University

1,448 total trials

What NCT07253532 shows while recruiting

NCT07253532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which BalanceBelt is the first listed.

NCT07253532 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07253532 about?

NCT07253532 is a clinical study titled "Vibrotactile Balance Belt Effect on Improving Gait". This study will examine the effect of using a vibrotactile feedback implemented into a belt, at improving gait in those with gait disorders.

What is the current status of trial NCT07253532?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-03-20. Estimated completion is 2030-12-01.

What interventions are being tested in trial NCT07253532?

The interventions under investigation include: BalanceBelt (DEVICE).

Who is sponsoring clinical trial NCT07253532?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07253532's enrollment target sits among peer trials

90 941st of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07253532, the US trial registry maintained by the National Library of Medicine. NCT07253532 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.